SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000880771-16-000208
Filing Date
2016-11-09
Accepted
2016-11-09 16:32:07
Documents
60
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scln-20160930x10q.htm 10-Q 1483180
2 EX-31.1 scln-20160930xex31_1.htm EX-31.1 18307
3 EX-31.2 scln-20160930xex31_2.htm EX-31.2 18315
4 EX-32.1 scln-20160930xex32_1.htm EX-32.1 12582
5 EX-32.2 scln-20160930xex32_2.htm EX-32.2 15441
  Complete submission text file 0000880771-16-000208.txt   5115352

Data Files

Seq Description Document Type Size
6 EX-101.INS scln-20160930.xml EX-101.INS 1068674
7 EX-101.SCH scln-20160930.xsd EX-101.SCH 35256
8 EX-101.CAL scln-20160930_cal.xml EX-101.CAL 45043
9 EX-101.DEF scln-20160930_def.xml EX-101.DEF 85560
10 EX-101.LAB scln-20160930_lab.xml EX-101.LAB 251546
11 EX-101.PRE scln-20160930_pre.xml EX-101.PRE 212097
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 161984668
SIC: 2834 Pharmaceutical Preparations